Form EFFECT Cidara Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 9, 2026 |
| Accession Number: | 0001193125-26-005773 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Basil Resale Highlights Used and Certified Pre-Owned Vehicle Inventory Priced Under $20,000
- Marijuana Rescheduling or Regulatory Failure? D.C. Appellate Court Will Rule
- Litecoin Price Prediction: LTC Loses $41 Support as MemeToro Nears Completion of Its Stage 1 Raise
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
